Phase I clinical trials in South Korea are conducted under strict guidelines set by the Ministry of Food and Drug Safety (MFDS). These trials focus on assessing safety, dosage, and pharmacokinetics in a small group of healthy volunteers. Compliance with Good Clinical Practice (GCP) standards and ethical review board approval is required.
